Biguanides;Biguanides

Actualites Pharmaceutiques

Volumn 50, Issue 506, 2011, Pages 51-54

  Faure, Sébastien ^a  

^a UNIVERSITÉ D'ANGERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIGUANIDE DERIVATIVE; DIABAMYL; GLIBENCLAMIDE PLUS METFORMIN; GLITAZONE DERIVATIVE; HEMOGLOBIN A1C; METFORMIN; METFORMIN EMBONATE; METFORMIN PLUS PIOGLITAZONE; METFORMIN PLUS SITAGLIPTIN; UNCLASSIFIED DRUG;

ARTICLE; DISEASE COURSE; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG MECHANISM; DRUG METABOLISM; FRANCE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT RESPONSE;

EID: 79960457383     PISSN: 05153700     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0515-3700(11)70972-7     Document Type: Article

References (3)

1. Agence franaise de sécurité sanitaire des produits de santé (Afssaps) et Haute Autorité de santé (HAS). Consensus 2006: traitements médicamenteux du diabte de type 2. www.has-sante.fr.
2. R.S. Legro, H.X. Barnhart, and W.D. Schlaff Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. Cooperative Multicenter Reproductive Medicine Network N Engl J Med 356 2007 551 566
3. J.G. Boyle, P.J. Logan, and G.C. Jones AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover study Diabetologia 2011 sous presse